Off-the-shelf T-cell therapy

Laurence J.N. Cooper

doi:10.1182/blood-2010-10-308379

Off-the-shelf T-cell therapy

Laurence J.N. Cooper

Pediatrics

Research output: Contribution to journal › Comment/debate › peer-review

9 Scopus citations

Abstract

In this issue of Blood, Barker et al demonstrate that third-party non-neonatal Tcells specific for Epstein-Barr virus (EBV) can be safely used to treat EBV-associated disease after allogeneic umbilical cord blood (UCB) transplantation (UCBT).¹ This is made possible by the a priori generation of cryopreserved banks of EBV-specific T cells from peripheral blood.

Original language	English (US)
Pages (from-to)	4741-4743
Number of pages	3
Journal	Blood
Volume	116
Issue number	23
DOIs	https://doi.org/10.1182/blood-2010-10-308379
State	Published - Dec 2 2010

ASJC Scopus subject areas

Biochemistry
Immunology
Hematology
Cell Biology

Access to Document

10.1182/blood-2010-10-308379

Cite this

@article{ceef513069404e2fa6f1126d513ec84d,

title = "Off-the-shelf T-cell therapy",

abstract = "In this issue of Blood, Barker et al demonstrate that third-party non-neonatal Tcells specific for Epstein-Barr virus (EBV) can be safely used to treat EBV-associated disease after allogeneic umbilical cord blood (UCB) transplantation (UCBT).1 This is made possible by the a priori generation of cryopreserved banks of EBV-specific T cells from peripheral blood.",

author = "Cooper, {Laurence J.N.}",

year = "2010",

month = dec,

day = "2",

doi = "10.1182/blood-2010-10-308379",

language = "English (US)",

volume = "116",

pages = "4741--4743",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "23",

}

TY - JOUR

T1 - Off-the-shelf T-cell therapy

AU - Cooper, Laurence J.N.

PY - 2010/12/2

Y1 - 2010/12/2

N2 - In this issue of Blood, Barker et al demonstrate that third-party non-neonatal Tcells specific for Epstein-Barr virus (EBV) can be safely used to treat EBV-associated disease after allogeneic umbilical cord blood (UCB) transplantation (UCBT).1 This is made possible by the a priori generation of cryopreserved banks of EBV-specific T cells from peripheral blood.

AB - In this issue of Blood, Barker et al demonstrate that third-party non-neonatal Tcells specific for Epstein-Barr virus (EBV) can be safely used to treat EBV-associated disease after allogeneic umbilical cord blood (UCB) transplantation (UCBT).1 This is made possible by the a priori generation of cryopreserved banks of EBV-specific T cells from peripheral blood.

UR - http://www.scopus.com/inward/record.url?scp=78649744678&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649744678&partnerID=8YFLogxK

U2 - 10.1182/blood-2010-10-308379

DO - 10.1182/blood-2010-10-308379

M3 - Comment/debate

C2 - 21127184

AN - SCOPUS:78649744678

SN - 0006-4971

VL - 116

SP - 4741

EP - 4743

JO - Blood

JF - Blood

IS - 23

ER -

Off-the-shelf T-cell therapy

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this